Core Laboratories stock analysis
Core Laboratories (CEI) Stock Price & Analysis
CEI Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- CHF 325.54M
- Enterprise Value
- CHF 599.81M
- Total Cash (Recent Filing)
- CHF 21.38M
- Total Debt (Recent Filing)
- CHF 161.97M
- Price to Earnings (P/E)
- 25.1
- Beta
- N/A
- Next Earnings
- Feb 03, 2027 (Est.)
- EPS Estimate
- 0.13
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Improved Balance Sheet
Materially lower leverage and a steadily growing equity base strengthen Core Lab’s financial resilience. This provides more flexibility to fund technology, manage cyclical customer spending, and return capital while reducing the balance-sheet pressure associated with weaker operating conditions.
Proprietary Technology And Customer Retention
Successful deployment of proprietary technologies followed by a five-year contract indicates differentiated capabilities and embedded customer relationships. These solutions can support recurring work, improve switching resistance, and create durable demand beyond individual laboratory or field-service projects.
Asset-light Cash Generation Model
The asset-light model limits routine capital intensity and can support cash generation as activity improves. Modest ongoing investment requirements leave more resources for technology development, debt management, dividends, and buybacks without requiring proportionate spending on physical assets.
Bears Say
Revenue And Margin Deterioration
The sharp TTM revenue contraction and lower gross and net margins show weakened operating leverage and reduced earnings power. If demand remains uneven, lower utilization and pricing pressure could limit profitability and make recovery dependent on a sustained improvement in customer programs.
Geopolitical Operating Disruption
Geopolitical disruption is affecting several parts of Core Lab’s service model, including project execution, field operations, logistics, and shipments. Continued disruption could defer revenue, increase regional carrying costs, and keep customer activity below potential over the next several months.
Uneven Cash Conversion And Working Capital
Limited third-quarter free cash flow alongside higher receivables and inventory indicates that earnings are not converting consistently into cash. Collection timing and inventory needs can absorb liquidity, constrain capital allocation, and reduce the financial benefit of any operating recovery.
Core Laboratories News
CEI FAQ
What is Core Laboratories’s market cap?
When is Core Laboratories’s upcoming earnings report date?
How were Core Laboratories’s earnings last quarter?
Is Core Laboratories overvalued?
Does Core Laboratories pay dividends?
What is Core Laboratories’s EPS estimate?
What happened to Core Laboratories’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Core Laboratories?
What is the TipRanks Smart Score and how is it calculated?
Core Laboratories Stock Smart Score
Company Description
Core Laboratories
Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.
- Sector
- Energy
- Industry
- Oil & Gas Equipment & Services
- CEO
- Lawrence V. Bruno
- Employees
- 3,300
- Website
- www.corelab.com
- Address
- 6316 Windfern Road, Houston, TX, 77040, US
Core Laboratories (CEI) Earnings & Revenues
CEI Earnings Call
Earnings Call SentimentNeutral
The call was balanced. Core Lab reported meaningful sequential improvements in revenue, operating income, margins, product sales and EPS, along with several technology wins, a 5-year contract and expectations for stronger global activity in 2027. However, geopolitical conflicts continued to depress year-over-year service and Reservoir Description results, reduce demand for crude assay work, delay projects, constrain cash flow and create uncertainty. Fourth-quarter revenue is expected to remain relatively flat, making the overall tone neutral despite management's constructive longer-term outlook.
View all CH:CEI earnings summaries








